Cachexia
Not recruitingStudy of ponsegromab for patients with cancer cachexia and elevated GDF-15 levels
- Disease:Cachexia
- Substances:Ponsegromab
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Ponsegromab
- Sponsor:Pfizer Inc.
Rare diseases
Investigational molecules
Locations
Back to Bulgaria99 clinical trials in Burgas, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lung cancer and breast cancer treatments, including studies of novel therapies for metastatic conditions. Research encompasses both targeted and immunotherapy approaches.
Emphasis on developing treatments for patients with specific genetic markers and testing new combination therapies.
Comprehensive research into cardiovascular disease prevention and treatment, including innovative approaches to managing atherosclerosis and stroke prevention.
Multiple trials evaluating new compounds for lipid management and cardiovascular risk reduction.
Studies focused on chronic respiratory conditions including COPD and asthma, testing advanced inhalation therapies and novel treatment approaches.
Investigation of new therapeutic combinations and delivery systems for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.